Cargando…
SEOM clinical guideline on heritable TP53-related cancer syndrome (2022)
Li-Fraumeni syndrome is caused by heterozygous germline pathogenic variants in the TP53 gene. It involves a high risk of a variety of malignant tumors in childhood and adulthood, the main ones being premenopausal breast cancer, soft tissue sarcomas and osteosarcomas, central nervous system tumors, a...
Autores principales: | Sánchez-Heras, Ana Beatriz, Ramon y Cajal, Teresa, Pineda, Marta, Aguirre, Elena, Graña, Begoña, Chirivella, Isabel, Balmaña, Judit, Brunet, Joan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425559/ https://www.ncbi.nlm.nih.gov/pubmed/37133731 http://dx.doi.org/10.1007/s12094-023-03202-9 |
Ejemplares similares
-
SEOM clinical guidelines in Hereditary Breast and ovarian cancer
por: Llort, G., et al.
Publicado: (2015) -
Clinical guideline seom: hereditary colorectal cancer
por: Guillén-Ponce, C., et al.
Publicado: (2015) -
SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022)
por: Garcia-Saenz, Jose Angel, et al.
Publicado: (2023) -
SEOM SOGUG clinical guideline for treatment of kidney cancer (2022)
por: Méndez-Vidal, María José, et al.
Publicado: (2023) -
SEOM-GEINO clinical guidelines for high-grade gliomas of adulthood (2022)
por: Segura, Pedro Pérez, et al.
Publicado: (2023)